Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2

Conditions

Sarcoma 16Osteosarcoma 8Neuroectodermal Tumors, Primitive, Peripheral 3Liposarcoma 3Hemangiopericytoma, Malignant 3Gliosarcoma 3Glioblastoma 3Fibrosarcoma 3Brain Neoplasms 3Malignant mesenchymal tumor 2Hemangiosarcoma 2Glioma 2Gastrointestinal Stromal Tumors 2Desmoplastic Small Round Cell Tumor 2Dermatofibrosarcoma 2Central Nervous System Neoplasms 2Astrocytoma 2Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Neurofibrosarcoma 1Neoplasms 1Neoplasm Metastasis 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Chondrosarcoma, Extraskeletal Myxoid 1Chondrosarcoma 1Cardiotoxicity 1

Interventions

Imatinib Mesylate 71Sunitinib 31regorafenib 17nilotinib 15ripretinib 13avapritinib 7Laparoscopy 5Ipilimumab 5Dasatinib 5spartalizumab 4CTLA-4 Antigen 4Blood Specimen Collection 44-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 4pexidartinib 3pazopanib 3binimetinib 3Temozolomide 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Paclitaxel 3Oxaliplatin 3Observation 3Nivolumab 3Midazolam 3Leucovorin 3Gemcitabine 3Biopsy 3Bevacizumab 3trametinib 2tanespimycin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gastrointestinal Stromal Tumors × Neoadjuvant Therapy × Sarcoma × Clear all
NCT04933669 2021-10-12

ZJGIST-01

First Affiliated Hospital of Zhejiang University

Phase 2 Recruiting
122 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00112632 2012-03-08

Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor

Technical University of Munich

Phase 2 Completed
40 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡